Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioIVT, operating legally as IVT Holdings Inc., is a leading global provider of high-quality biological specimens and specialized in vitro research services for the pharmaceutical and biotechnology industries. The company specializes in the procurement and characterization of human and animal tissues, cell products, blood, and other biofluids essential for drug discovery and development. BioIVT is particularly renowned for its expertise in ADME-Tox research, offering a comprehensive portfolio of hepatocytes and transporter assays to support pharmacokinetic studies. Through strategic acquisitions of companies like Ascendance Biotechnology and Asterand Bioscience, BioIVT has expanded its capabilities to include advanced disease-state models and specialized cell-based assays. The company serves as a critical partner for researchers by providing the biological materials necessary to understand drug metabolism and disease processes in a laboratory setting. Headquartered in Westbury, New York, BioIVT maintains a global footprint with facilities across North America, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IVT Holdings.